BYAH Park Ha Biological Technology Co., Ltd.
Price Chart
Executive Summary
Park Ha Biological Technology Co., Ltd. (BYAH) announced a comprehensive strategic partnership with Star Plus Action (HK) Limited, a wholly-owned subsidiary of Star Plus Legend Holdings Limited (6683.HK), to integrate resources in healthcare, skincare, celebrity IP management, and AI technology. The partnership includes the launch of an 'AI Nutritionist' pilot product and plans for AI-powered store managers and skincare specialists, aiming to build an AI-powered skincare and health ecosystem. No financial terms, revenue impact, or material financial data were disclosed in the filing.
Actionable Insight
The partnership is a non-binding strategic announcement with no financial details, making it a low-conviction catalyst. Monitor for subsequent filings that disclose revenue-sharing terms, investment amounts, or product launch milestones. The stock's micro-cap status ($5M market cap) amplifies volatility risk on any news flow.
Key Facts
- Park Ha entered a strategic partnership with Star Plus Action (HK) Limited, a wholly-owned subsidiary of Star Plus Legend Holdings Limited (6683.HK), on June 12, 2026.
- The partnership covers product development, IP empowerment, AI agents, offline scenarios, user operations, digital innovation, and global expansion.
- The first collaborative product, the 'AI Nutritionist,' has been launched as a pilot.
- No financial terms, investment amounts, or revenue projections were disclosed in the filing.
- Park Ha operates 3 directly operated stores and 39 franchisees in China as of April 30, 2025.
- The company has a market capitalization of approximately $5 million.
Financial Impact
No financial terms disclosed; partnership is strategic with no stated investment or revenue contribution.
Risk Factors
- No financial terms disclosed — partnership may not generate material revenue.
- Micro-cap stock with limited liquidity and high volatility.
- Forward-looking statements about AI deployment and ecosystem building are unproven and subject to execution risk.
- Cross-filing context includes a 20-F annual report filed 102 days ago, but no material financial updates or risks were highlighted in this 6-K.
Market Snapshot
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001213900-26-068014 |
| Document: ea029459601ex99-1.htm | 0001213900-26-068014 |
| Document: 0001213900-26-068014-index-headers.html | 0001213900-26-068014 |
| Document: 0001213900-26-068014-index.html | 0001213900-26-068014 |
| Document: 0001213900-26-068014.txt | 0001213900-26-068014 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 12, 2026
today
|
6-K
| $1.59 awaiting T+1 | awaiting T+1 | — | $1.47 (+7.55%) |
|
Jun 12, 2026
today
|
Press Release
| $1.99 awaiting T+1 | awaiting T+1 | — | $1.47 (+26.13%) |
|
Jun 12, 2026
1d ago
|
6-K
| $2.81 awaiting T+1 | awaiting T+1 | — | $1.47 (−47.69%) |
|
Jun 9, 2026
4d ago
|
EFFECT
| $1.50 awaiting T+1 | awaiting T+1 | — | $1.47 (−2.00%) |
|
Jun 4, 2026
9d ago
|
6-K
| $1.29 $1.06 | ▼ −17.89% | ▼ −15.29% | $1.47 (+13.87%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access